SKI Market

A+| A| A-|

Indian Indices

Sensex

74,538.42 619.66
( 0.84%)

Global Indices

Nasdaq

50,884.98 77.97
(0.15%)

Dow Jones

7,407.31 -19.42
(-0.26%)

Hang Seng

64,234.22 -1,182.41
(-1.81%)

Nikkei 225

10,242.24 -130.96
(-1.26%)

Forex

USD-INR

95.53 0.30
(0.32%)

EUR-INR

110.14 0.47
(0.43%)

GBP-INR

127.43 0.45
(0.36%)

JPY-INR

0.60 0.00
(0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Navkar Corporation Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

539332

INE278M01019

130.080377

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NAVKARCORP

48.8

1469.07

EPS(TTM)

Face Value()

Div & Yield %

Back

Jenburkt Pharmaceuticals standalone net profit declines 8.91% in the December 2025 quarter

Feb 03,2026

Net profit of Jenburkt Pharmaceuticals declined 8.91% to Rs 5.93 crore in the quarter ended December 2025 as against Rs 6.51 crore during the previous quarter ended December 2024. Sales rose 16.62% to Rs 43.02 crore in the quarter ended December 2025 as against Rs 36.89 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	43.02	36.89	17
OPM %	17.27	23.94	-
PBDT	9.13	10.30	-11
PBT	8.30	9.52	-13
NP	5.93	6.51	-9

74,538.42 619.66 ( 0.84%)

50,884.98 77.97 (0.15%)

7,407.31 -19.42 (-0.26%)

64,234.22 -1,182.41 (-1.81%)

10,242.24 -130.96 (-1.26%)

95.53 0.30 (0.32%)

110.14 0.47 (0.43%)

127.43 0.45 (0.36%)

0.60 0.00 (0.41%)